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Single-Molecule 3D Images of 
“Hole-Hole” IgG1 Homodimers 
by Individual-Particle Electron 
Tomography
Dongsheng Lei1, Jianfang Liu1, Hongbin Liu2, Thomas E. Cleveland IV  3, John P. Marino3, 
Ming Lei  2 & Gang Ren1
The engineering of immunoglobulin-G molecules (IgGs) is of wide interest for improving therapeutics, 
for example by modulating the activity or multiplexing the specificity of IgGs to recognize more than 
one antigen. Optimization of engineered IgG requires knowledge of three-dimensional (3D) structure 
of synthetic IgG. However, due to flexible nature of the molecules, their structural characterization is 
challenging. Here, we use our reported individual-particle electron tomography (IPET) method with 
optimized negative-staining (OpNS) for direct 3D reconstruction of individual IgG hole-hole homodimer 
molecules. The hole-hole homodimer is an undesired variant generated during the production of a 
bispecific antibody using the knob-into-hole heterodimer technology. A total of 64 IPET 3D density 
maps at ~15 Å resolutions were reconstructed from 64 individual molecules, revealing 64 unique 
conformations. In addition to the known Y-shaped conformation, we also observed an unusual X-shaped 
conformation. The 3D structure of the X-shaped conformation contributes to our understanding of the 
structural details of the interaction between two heavy chains in the Fc domain. The IPET approach, as 
an orthogonal technique to characterize the 3D structure of therapeutic antibodies, provides insight 
into the 3D structural variety and dynamics of heterogeneous IgG molecules.
Immunoglobulin-G molecules (IgGs) are the predominant component of humoral immunity. In clinical 
practice, recombinant IgGs have been used to treat a wide array of diseases, including cancer1–3, rheumatoid 
arthritis4–6, and many auto-immune diseases7–10. Recently, advances in IgG engineering have enabled the devel-
opment of monoclonal antibodies with the potential to recognize more than one antigen, such as bispecific and 
multi-specific antibodies11–13. Among them, bispecific antibodies are being evaluated for the treatment of cancer 
through activation of T-cell killing14–16 and potential reduction of the non-target toxicities of loaded antibodies 
such as antibody-drug conjugates (ADCs)17,18. Over the past 20 years, many platforms have been designed and 
evolved to produce bispecific IgG, such as strand-exchange engineered domain (SEED)19, electrostatic steer-
ing20, IgG4 Fab-arm exchange21, Diabodies22, and CovX-Bodies23,24. However, the main challenge remains to 
improve the yield of heterodimer and suppress homodimerization. One approach to address this challenge is the 
“knob-into-holes” system that involves a “knob” mutation (T366W) in one-half of the Fc CH3 domain and “hole” 
mutations (T366S, L368A and Y407V) in the other half. This system promotes hetero-dimerization through the 
pairing of the “knob” and the “hole”. Thus far, this system has been successfully implemented in the production 
and purification of several therapeutic bispecific antibodies at various clinical stages25,26.
The main variants generated from this system are hole-hole homodimers and, to a lesser extent, knob-knob 
homodimers, which are both product-related impurities and should be mostly removed through assembly and 
purification steps. To evaluate the performance of the purification, the levels of these homodimers were mon-
itored. These homodimers showed unexpected behavior not normally observed in conventional monoclonal 
IgG antibodies (mAbs)27, such as a pH-dependent interchange between several peaks, which were separated 
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on hydrophobic interaction chromatography and represented different forms of the hole-hole homodimer 
with the same mass27. The unexpected behavior of the hole-hole homodimers are related to the mutations in 
the CH3 domain and challenge the development of suitable analytical methods to monitor and understand 
the difference in the homodimer forms. Therefore, various modes of chromatography, native mass spectrom-
etry (MS) and hydrogen-deuterium exchange MS (HDX-MS) were used to identify the structural basis for the 
pH-dependent interchange of the hole-hole homodimer forms27. The analytical results indicate that higher-order 
structure-related changes are responsible for the different hole-hole homodimer forms. The HDX-MS data 
showed a local increase in deuterium exchange in the CH2 and CH3 regions, but understanding its impact on the 
overall conformation of the homodimer will require further study. Additional higher-order structure differences 
that were not observed by HDX-MS may remain to be discovered.
The traditional methods used to determine the three-dimensional (3D) structure of proteins include X-ray 
crystallography and nuclear magnetic resonance (NMR) spectroscopy. Each method has certain disadvantages: 
flexible molecules such as IgGs are difficult to crystallize and IgGs are also too large to be amenable to de novo 
NMR structural determination. In recent years, single particle cryo-electron microscopy (cryo-EM) has become 
an important technique to determine the averaged 3D structure of a type of protein28,29.
Single particle cryo-EM now has the capability for structure determination of protein at atomic resolution 
under near-native buffer conditions30. However, this method also has its own limitations, such as difficulties in 
imaging small proteins (<50 kDa) and in achieving low-resolution 3D maps of flexible macromolecules. These 
flexible macromolecules include DNA and RNA, lipoprotein, antibodies31 and human immunodeficiency virus 
among many others. The problem for imaging using this technique originates from the averaging concept, in 
which the tens of thousands and more atoms within each particle are assumed to have identical arrangements. 
This assumption is largely suitable for rigid particles but becomes less so with increasing conformational flexi-
bility and dynamics. Averaging over hundreds of thousands of particles can often cause anisotropic resolution32 
and the loss of domains28 in the final 3D reconstruction, although other portions of the molecule may show 
atomic resolution. Moreover, even in cryo-EM, sample preparation artifacts can be present. The thin water film 
used for cryo-EM specimens can often cause proteins to adopt a preferred orientation in the ice, which can be 
unduly influenced by the air-water interface33. In addition, the air-water interface can induce proteins to denature 
or aggregate, and complexes to dissociate34. In comparison, although negative staining (NS) remains useful as 
a supplementary method to study small and flexible proteins at a low-resolution, but with high contrast. Some 
disadvantages of NS remain, such as stain artifacts, complex dissociation, stain-induced chemical reactions and 
substrate interaction. Therefore, no sample preparation method is perfect.
Preliminary NS-EM 2D images showed that the hole-hole homodimers are heterogeneous in structure27. 
Unlike in the conventional Y-shaped conformation, it was observed that in some particles, the CH2 and CH3 
domains of the Fc of the homodimers were distant from each other27, displaying an “X-shaped” conformation. 
However, geometric analysis based on these 2D images was insufficient to uncover the detailed 3D structure or 
the extent of the structural flexibility.
To obtain the 3D structure of the hole-hole homodimers, the optimized negative-staining (OpNS)35–38 
method was used to prepare the EM specimen, and both conventional single-particle class averaging and then the 
individual-particle electron tomography (IPET) method24,39,40 was used to obtain the 3D reconstructions. 
Reconstructing 64 IPET 3D density maps of the IgG hole-hole homodimers at a resolution of ~15 Å were used 
to derive 64 conformations of the IgG homodimers via flexible docking (“hand-in-glove”) of a crystal structure 
of IgG (PDB entry 1HZH41) into the envelope of each IPET 3D density map. Additional statistical analysis on 
the geometry of the IgG homodimers (domain distance and angle) investigated the conformational variety and 
flexibility among the domains and provided a mean to quantitatively understand the differences in structural 
flexibility between a regular antibody and the hole-hole homodimer.
Results
Morphology of IgG hole-hole homodimers. The IgG hole-hole homodimers produced as a side product 
from the assembly of the knob-into-hole bispecific antibody were examined by OpNS EM (Fig. 1A–D)35–38. The 
OpNS protocol was refined from conventional NS protocols by introducing three additional steps: (i) filtering the 
thawed staining solution (1% Uranyl formate, UF) using the smallest available filter (0.02 μm) to remove the pre-
cipitated particles immediately before usage (the newly prepared 1% UF was aliquoted into 2 mL/vial and stored 
at −20 °C), (ii) incubating and then staining the EM grid within a black box to prevent the stain reagent from the 
light-exposure, and (iii) drying the specimen with nitrogen gas to prevent sample oxidation. The OpNS protocol 
can limit certain artifacts, such as Rouleau formation for lipoprotein particles35–38, and has been used to examine 
many biological macromolecules24,27,35–38,40,42–62, including antibodies24,27,49,53, cholesteryl ester transfer protein 
(CETP)46, phospholipid transfer protein (PLTP)63, liposome-CETP complex42, lipoproteins and their antibody 
complexes35,38,43,58, GroEL and Proteosome37, Contactin-associated Protein-like 2 (CNTNAP2)59, Calsyntenin-340, 
Neurexin 1𝛼51, 84-base pair dsDNA conjugated with 5 nm nanogold57, and DNA origami52. These studies demon-
strate that OpNS is a suitable and reliable protocol to examine the structure and morphology of small, and/or 
flexible proteins.
OpNS-EM images of the IgG hole-hole homodimer showed evenly distributed particles (Fig. 1A, after band-
pass filtering between 8 Å and 2,000 Å). Most particles had a dimension of ~150–190 Å, which is similar to that 
of regular IgGs49. Zoom-in images showed that most particles have a Y-shape (~60.6%) (Fig. 1B). Unexpectedly, 
many particles (~26.9%) displayed as X-shape (Fig. 1C, Supplementary Video 1), bow-tie shape (~10.0%) or even 
i-shape (~2.5%) (Fig. 1D). The Y-shaped particles had a similar structure to regular IgGs49, while the X-shaped 
particles contained four apparent domains: two large ring-shaped domains and two small rod-shaped domains 
(Fig. 1E). The two ring-shaped domains, likely to be Fab domains, were similar to each other in size (overall 
diameter) and shape (aspect ratio). The two small rod-shaped domains were similar to each other and were likely 
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the CH2 and CH3 domains of the heavy chain, i.e., an Fc domain in which the two heavy chains were separated 
from each other (Fig. 1E). Two domains of the bow-tie shaped particles have a similar size and shape to each 
other and Fab domains, while the Fc domain is apparently absent, possibly denatured. The i-shaped particles 
were similar to half of an X-shaped particle in size and shape, likely composed of a Fab domain and half of an Fc 
domain (Fig. 1E–I).
To evaluate whether the observed X-shaped particle was statistically significant in its abundance, we per-
formed a reference-free classification based on 13,546 particles. The high-contrast 2D class averages confirmed 
all Y-shaped, X-shaped, i-shaped and bow-tie shaped particles (Fig. 1J–L). The difference between the Y- and 
X-shaped particles was within the conformation of the Fc domains, in which one of three domains in the 
Y-shaped particles converted into two small rod-shaped domains in the X-shaped particles.
The size and shape of domains within Y- and X-shaped class averages were similar to those of an IgG crystal 
structure (PDB entry 1HZH41), except for the split Fc domain of the X-shaped averages. The similarity allowed us 
to map 3D models to the 2D class averages following methods previously used in EM64–67 and AFM68,69. Although 
the class averages are insufficient for determining the 3D particle structures, they help us to understand the 
Figure 1. OpNS-EM images of IgG hole-hole homodimer sample. (A) A survey OpNS image of the IgG hole-
hole homodimer sample. Representative images of (B) Y-shaped, (C) X-shaped, and (D) i-shaped particles are 
shown. The last images of the Y-, X-, and i-shaped particles were superposed with diagrams to show the overall 
location of large domains (cyan ellipses) and small regions (green ellipses) within each particle. (E) Diagram 
of various conformations of IgG homodimer. (F) Representative raw images showing conformations in (E). 
(G) After erasing the noise areas outside particles, (H) images were superposed by using an IgG model (crystal 
structure of regular IgG, PDB entry 1HZH) to show the overall location of domains. (I) Obtained models show 
various conformations of IgG homodimer. All models are shown in ribbon representation, in which heavy 
chains are in yellow and magenta, and light chains are in cyan and green. (J) Representative reference-free 
class averages from 13,546 particles. Arrows indicate averages with fuzzy or blurry domains (K) Representative 
Y-shaped class averages. (L) Representative X-shaped class averages. (M) Class averages of Y- and X-shaped 
particles in various conformations. (N) After erasing noise areas outside particles, (O) the averages were 
superposed using the IgG model to show the overall location of Fab, Fc or half Fc domains (detail provided in 
Methods section). During superposing, the location and orientation of domains within models were required 
to be adjusted to fit to each average. (P) Obtained models show overall conformations of IgG homodimer. Scale 
bars = 20 nm in A and 10 nm in (B–P).
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overall shape and conformational variety in terms of the domain locations (Fig. 1M–P). During the mapping, 
we found that no matter how we changed the orientations of the antibody, the projection of the model could not 
match well with some Y-shaped and all X-shaped averages, unless we adjusted the structure of the hinge region 
to allow the domains to move and change their orientations. The new locations and orientations allowed us to 
match the Y-shaped particle easily (Fig. 1M–P, first column). For X-shaped particles, an additional operation 
was needed; i.e., the two halves of the heavy chains of the Fc domain (two copies of CH2 and CH3 domains) must 
be separated from each other to match to the rod-shaped densities in the 2D averages of the X-shaped parti-
cles (Fig. 1M–P, last four columns). The wide range of orientations between the two copies of the CH2 and CH3 
domains of the Fc suggested that X-shaped particles were more flexible than Y-shaped particles. Similarly, the 
above mapping method was also applied to the raw images of Y-shaped and X-shaped particles to confirm the 
flexibilities of particles (Fig. 1F–I).
Evaluation of potential artifacts from NS and substrate interactions using the NISTmAb. 
Although the OpNS protocol has been used to examine more than 20 types of macromolecules for high-contrast 
imaging37,53, one may still question whether the antibody-substrate interaction or the low pH of the uranyl for-
mate NS causes noticeable artifacts. These artifacts could include conformational changes or the domain dissoci-
ation observed in the X-shaped particles.
In principle, cryo-EM is the ideal approach to examine the proteins in near-native solution conditions without 
artifacts from NS. Practically, however, it is very challenging to image the antibody by itself (not antibody-antigen 
complex) due to its low molecular weight and floppy structure (three relatively isolated ~50 kDa domains linked 
by a flexible hinge region). Generally, proteins of molecular weight less than 50 kDa are beyond current limi-
tations of cryo-EM structural determination. Although antibodies comprise more than 10% of human plasma 
proteins, and are highly desired for pharmaceutical drug design, no cryo-EM 3D reconstruction has been 
reported according to our best knowledge. While cryo-electron tomography (ET) 3D reconstructions have been 
reported70,71, no raw data or intermediate results have been shown in the publications. Moreover, one publica-
tion using the same approach was retracted due to low reliability (more than 90% of the reconstructions were 
invalid based on third-party evaluation using IMOD reconstructions)72,73. Thus, cryo-EM is still challenging as a 
practical approach for studying antibody structure. We therefore supported our NS methodology using identical 
studies of a control antibody.
To examine whether the X-shaped particles were related to artifacts from the NS or substrate interaction, 
we used the same NS protocol and supporting substrate to examine the NISTmAb, a standard monoclonal anti-
body provided by National Institute of Standard Technology (NIST), which is available as a reference mate-
rial (RM 8671)74. NISTmAb is an IgG1 antibody performance standard useful for evaluation/development of 
state-of-the-art and emerging analytical measurement technologies75,76. The material has been used extensively 
to evaluate current best practices for mAb characterization and develop innovative analytical technologies. 
The survey image showed evenly distributed NISTmAb particles with a “Y” shape with dimensions of ~150–
180 Å (Fig. 2A). The particles were composed of three ring-shaped domains of ~55–75 Å in diameter (Fig. 2B), 
which were similar to those of crystal structures (PDB entry, 1HZH41). No X-shaped particle was observed. The 
reference-free class averages from ~4,961 particles confirmed that a “Y”-shaped structure was the only species in 
the sample (Fig. 2C). The result was consistent to the early reports; i.e., no X-shaped particles were observed in 
other IgG samples by using same NS protocol24,27,37–39. Although the pH of the staining is as low as ~4.5, which is 
different from the pH of the samples, it has been reported that UF can fix protein structure within a few millisec-
onds77, which may explain the lack of apparent of pH induced artifacts.
Although we could not exclude the possibility that the flexibility of antibodies could be influenced by the 
substrate interactions, we find it unlikely that the X-shaped antibody was solely an artifact of NS, and conclude 
that the X-shape is an intrinsic conformation of the hole-hole IgG homodimer. This result is also consistent with 
multiple orthogonal methods, including chromatography, native MS and HDX-MS27.
The limitations of conventional single-particle averaging in 3D reconstruction. To understand 
the detailed structure of the X-shaped particles, a 3D structure was required as projections were often insuffi-
cient. Although single-particle class averaging is the dominant technique for 3D structural determination, the 
method has limitations in the reconstruction of flexible proteins. This is because it requires not only an initial 
model but also the assumption of identical particles in 3D structure (or at least, a small number of discrete 
structures)78. Using this averaging method, the 3D reconstructions were either significantly dependent on the 
given initial models or gave structurally impossible solutions49. To demonstrate the limitations of single-particle 
reconstruction on the hole-hole homodimer, we used the EMAN software package78 for reconstruction. Since the 
underlying methodology of single-particle reconstruction is similar in other software packages, the phenomenon 
illustrated in the example is also expected from other software packages.
For 3D reconstruction by single-particle averaging, two types of initial models were used: a cluster of ellipsoids 
representing domains  and a single Gaussian blob representing an entire antibody (Supplementary Fig. S1)78. In 
the domain models, four arrangements of ellipsoids were tried: two models consisted of three ellipsoidal blobs 
forming a Y-shape with angles of 150° and 45° respectively (Supplementary Fig. S1A, left two); while the other 
two models consisted of two large and two small ellipsoidal blobs forming an X-shape and cross-shape, respec-
tively (Supplementary Fig. S1A, right two). In the full-antibody models, the initial models consisted of a single 
featureless ellipsoidal Gaussian blob at four noise levels (Supplementary Fig. S1C).
Through a multi-reference refinement process, the final single-particle 3D reconstructions achieved from the 
domain models showed domains having similar angles to the initial models (Supplementary Fig. S1B), suggesting 
an initial model bias. The final 3D reconstructions from the full-antibody models showed significantly different 
structures from the initial models, but none of them was consistent with the crystal structure (PDB: 1HZH). This 
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result demonstrates the limitations of single-particle 3D reconstruction on flexible proteins is consistent with the 
problems reported in previous publications on IgG1 molecules49. Furthermore, these phenomena are anticipated 
for single-particle 3D reconstructions regardless of which software packages are used. It has been reported that 
common artifacts in single-particle 3D reconstruction (averaging) include the presence of blurry domains79, 
smaller than the expected dimensions of domains, uneven distribution of resolutions32, and the absence of protein 
domains/regions80, such as two ankyrin repeat regions, which were absent in the atomic structure of TRPV128. 
Given the limitations of the single-particle averaging reconstruction method in the structural determination of 
flexible proteins, we studied the hole-hole homodimer using the IPET approach, which has been tested on small 
and flexible macromolecules24,39,40,42,49–55,57–59,62.
IPET 3D reconstruction of individual particles. The IPET 3D reconstruction method was used to obtain 
the 3D map from each individual particle of the X-shaped, Y-shaped and i-shaped isomers (Figs 3 and 4). This 
method has demonstrated its ability to reconstruct 3D structures of flexible proteins49,52,57–59, including IgG149, 
peptide-conjugated IgG124, cholesteryl ester transfer protein (CETP) bound to lipoprotein54, and antibody bound 
to lipoproteins58,81. In IPET approach, particles were imaged from a series of tilt angles from −45° to 45° in 1.5° 
increments by electron tomography (ET) (Fig. 3A). The targeted particle was tracked and selected from each tilt 
series after contrast transfer function (CTF) correction. Unlike the single-particle 3D reocnstruction (an averag-
ing approach), no initial model was required. The first ab initio 3D reconstruction was directly generated from the 
experimental tilt images via a back-projection algorithm. These tilt images were iteratively aligned to their global 
centers to achieve a final 3D reconstruction via IPET approach. During the iterative alignment process, automati-
cally generated Gaussian low-pass filters and particle shaped soft-boundary masks were used to reduce the noise. 
A missing-wedge correction was also applied during the process (see Methods). The step-by-step refinement 
procedures and intermediate results are shown in Fig. 3B. The final 3D density map showed an overall Y-shaped 
particle (Fig. 3C) at a resolution of ~13.2 Å (Fig. 3E) based on the Fourier shell correlation (FSC) analysis as 
described49.
In the IPET reconstructions, the Y-shaped particle had an overall diameter of ~195 Å, and two of the three 
domains were similar to each other in size and shape (approximately 90 Å in diameter), suggesting that they were 
Fab domains. The third domain, which was different from other two domains in size, was likely the Fc domain. 
This IPET structure was consistent with the IgG crystal structure in overall size, domain shape and domain size, 
which allowed us to determine the overall particle conformation by flexibly docking the crystal structure (PDB: 
1HZH) into the map (details provided in the Methods section). To understand molecular conformation, we used 
an established method, flexible fitting of the high-resolution crystal structure into the low-resolution EM density 
map using molecular dynamics82–89. Although the docked model could not reveal the atomic resolution structure, 
it was sufficient to reveal the low-resolution conformation82,89,90.
Figure 2. OpNS-EM images of NISTmAb sample. (A) A survey OpNS image of NISTmAb sample. 
(B) Representative images of particles, and (C) representative class-averages from 4,961 particles. Scale 
bars = 30 nm in A, 10 nm in (B,C).
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During the docking process, which was similar to what has been reported49, the IPET 3D map was used as a 
constraint. The Fab domains and half Fc domain of the crystal structure were treated as rigid bodies to be oriented 
and inserted into the EM envelope through the rotation operator, maximizing the overlap between the domain 
structure and map (notably, the heavy chain and light chain in Fab domains are not distinguishable at the cur-
rent resolution). The hinge region was treated as a flexible structure to respond to the domain position changes, 
but under the constraints of chemical bonds and energy minimization. The final 3D conformation of the IgG 
homodimer was achieved by targeted molecular dynamics (TMD) simulations, maximizing the overlap between 
the structure and the density map while minimizing the energy of the structure. The quality of the fitting to the 
envelope was evaluated by the FSC curve computed between the model and density map (Fig. 3E,J).
By repeating the IPET 3D reconstruction on an X-shaped particle, we reconstructed a 3D map at ~13.7 Å 
resolution (Fig. 3G–K, Supplementary Video 1). The intermediate results of the iterative tilt series alignment 
(Fig. 3G) and the final 3D reconstruction showed a particle with an overall diameter of ~190 Å, containing two 
large dumbbell-shaped domains and two smaller domains (Fig. 3H). The two large domains, with similar lengths 
Figure 3. 3D reconstruction of two representative IgG homodimers by IPET. (A) OpNS samples of the IgG 
homodimer were imaged using ET from a series of tilt angles (from −45° to +45° at 1.5° intervals). Two 
homodimer particles (white circled) with orthogonal views are indicated by linked dashed arrows in three 
selected ET tilt micrographs. (B) Seven representative tilt images of an individual Y-shaped particle are 
displayed in the first column from the left. Using IPET, the tilt images (after CTF correction) were gradually 
aligned to a common center for 3D reconstruction via iterative refinement. Projections of raw, intermediate and 
final 3D reconstructions at corresponding tilt angles are displayed in the next five columns according to their 
corresponding tilt angles. (C) Final IPET 3D density map of targeted individual particle. The density map was 
low-pass filtered to 20 Å to reduce over-interpretation of high frequency or local noise. The ‘hide dust’ function 
was applied by Chimera. (D) The final 3D density map was flexibly docked with IgG crystal structure by using 
TMD simulation. (E) The resolution of IPET reconstruction was estimated by two Fourier shell correlation 
(FSC) curves. The first FSC curve (black solid line) was computed from two 3D maps that were back-projected 
from two sets of self-aligned tilt images (with even and odd tilt order numbers). The FSC curve fell below 
0.5 at ~13.2 Å, and fell below 0.143 at ~9.7 Å. The second FSC curve (blue dash line) was computed from the 
IPET reconstruction and the atomic resolution density map calculated from the fitted model. The FSC curve 
fell below 0.5 at ~31.4 Å and 0.143 at ~23.7 Å. (F) Five snapshots illustrated the conformational changes of the 
IgG model during TMD simulation. (G–K) The 3D density map of a second individual IgG homodimer was 
reconstructed from the tilt images using IPET. FSC analysis between the reconstructions from odd and even tilt 
images showed that FSC curve fell below 0.5 at ~13.7 Å and fell below 0.143 at ~9.6 Å (black solid line). The FSC 
analyses between the IPET final map and the map from the fitting model showed the FSC curve fell below 0.5 
at ~33.8 Å and fell below 0.143 at ~26.5 Å (blue dash line). IgG models are shown in ribbon representation, in 
which heavy chains are in yellow and magenta, and light chains are in cyan and green. Scale bars = 10 nm.
7Scientific RepoRts |          (2019) 9:8864  | https://doi.org/10.1038/s41598-019-44978-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
of ~80–90 Å and widths of ~40–50 Å, were likely the Fab domains. The small domains, with a length of ~80 Å and 
width of ~30 Å, were likely to be two halves of the Fc domain.
After flexibly docking the crystal structure into this map, the 3D conformation of the X-shaped particle 
(Fig. 3I,K, Supplementary Video 1) showed that the two halves of the Fc domain formed an angle of ~100° with 
a distance between the far ends of ~44 Å. This distance was rather large compared to the distance between two 
CH3 domains in the Y-shaped particle, where two CH3 domains were attached to each other. This large distance 
between two CH3 domains suggested a weak interaction.
By further repeating the above process, a total of 80 particles were targeted for IPET 3D reconstruction from 
a pool of ~250 particles acquired from four tilt series (Figs 3, 4 and 5, Supplementary Figs 2–45, Supplementary 
Table 1). A large number of particles were excluded due to particle-particle overlapping at certain tilt angles, miss-
ing tilted views, uneven surrounding stain backgrounds or already sufficient examples to present each species. 
The 80 IPET 3D maps included 16 maps from the Y-shaped particles, 48 maps from the X-shaped particles and 16 
maps from the i-shaped particles. The map resolutions were within a range of ~12 to ~15 Å. By flexibly fitting the 
crystal structure into these maps, we obtained 16 conformations for Y-shaped antibodies (Fig. 5B, Supplementary 
Figs 2–11), 48 conformations for X-shaped antibodies (Fig. 5D, Supplementary Figs 12–35) and 16 conformations 
for half antibodies (Fig. 4A–D, Supplementary Figs 36–45).
Resolution analysis on IPET 3D reconstruction. The resolution of IPET reconstruction was estimated 
by the following methods as reported49. (i) The single-particle method91,92, in which the resolution of the IPET 
reconstruction was estimated based on the matching of data to themselves by splitting the tilted images into 
two halves for reconstruction independently. The points where the FSC curve fell below 0.5 were used to repre-
sent the reconstruction resolution91,92. In this case, the resolution of the first reconstructed Y-shaped antibody 
was ~13.2 Å, while that of the first reconstructed X-shaped antibody was 13.7 Å (black solid lines in Fig. 3E,J). 
However, if we chose the “gold-standard” criteria93, i.e. using the point where the FSC curve fell below 0.143 as the 
resolution, the resolution of the Y-shaped antibody was ~9.7 Å, while that of the X-shaped antibody was ~9.6 Å 
(black solid lines in Fig. 3E,J). (ii) A model-to-map method, in which the resolution was estimated based on the 
matching of data to the best fitted model. The 3D density map of the best fitted structure using pdb2mrc software 
(EMAN package)78 was used to calculate the FSC curve against the IPET 3D map. The resolutions at which the 
FSC curves fell below 0.5 were ~31.4 Å for the Y-shaped antibody and ~33.8 Å for the X-shaped antibody (blue 
dash line in Fig. 3E,J). If we used “gold standard” criteria93, the resolutions were ~23.7 Å for the Y-shaped antibody 
Figure 4. Minor species, i-shaped and bow-tie-shaped particles, presented in IgG homodimer. (A) Six 
representative class averages of i-shaped particle based on OpNS images. (B) Two representative i-shaped 
particles were superposed by using a half-IgG model. (C) Sixteen density maps of i-shaped particle were 
reconstructed by using IPET. These density maps are presented in double contours. The inner contours are 
shown in cyan; outer contours are shown in transparent gray. (D) The density maps were flexibly docked with 
half-IgG models. (E) Five representative bow-tie-shaped particles. (F) Five representative bow-tie-shaped class 
averages. Scale bars = 10 nm.
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Figure 5. 3D conformation and conformational flexibility of IgG homodimer. (A) Sixteen density maps of 
Y-shaped IgG homodimers by IPET. (B) The density maps were flexibly docked using the crystal structure of a 
IgG to determine the overall conformations of corresponding maps. (C) Forty-eight density maps of X-shaped 
IgG homodimers by IPET. (D) The density maps were flexibly docked using the crystal structure of a IgG 
to determine the overall conformations of corresponding maps. The density maps are presented in double 
contours. The inner contours contoured surfaces are shown in cyan; outer contours are shown as transparent 
gray surfaces. (E) Sixteen Y-shaped conformations were aligned based on their CH2 domains. (F) Forty-eight 
X-shaped conformations were aligned based on their CH2 domains. Distributions of Y- and X-shaped IgG 
homodimers are shown from three orthogonal views. (G) Schematic model illustrating the distance between 
centers of CH3 domains (left) and the histogram of measured distance from 48 X-shaped homodimers (right). 
The histogram was fitted by using 2-term Gaussian model. (H) Schematic model illustrating the angle between 
the CH2 domains (left) and the histogram of the measured angle (right). (I) Schematic model illustrating 
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and ~26.5 Å for the X-shaped antibody. Notably, because the domains in the crystal structure were docked into 
the IPET maps as rigid bodies, the flexibility within the Fab and half Fc domains was not included in the resolu-
tion estimation, which may lead to an underestimated resolution. iii) A structural feature comparison method. 
The structural features included the maps of two heavy chain segments (CH2 and CH3) in the Fc domain. Since 
the dimension of CH2/CH3 was ~17 × ~18 × ~35 Å, the success in reconstructing the domains suggested the res-
olutions were roughly ~20 Å, consistent with the previous study of IgG149. To simplify estimation, we chose the 
frequency at which the FSC curve from single particle method fell below 0.5 (instead of 0.143) as an estimate of 
the resolution, as the previous publications24,39,40,49,52,57–59.
Statistical analysis of the conformational flexibility of 64 conformations. To reveal the flexibility 
of the newly found X-shaped particles, the 48 X -shaped particles were aligned to each other based on the structure 
of their CH2 domains. This alignment yielded an overall ball-like distribution in which both Fab domains and Fc 
domains adopted a wide range of angles and orientations (Fig. 5F). Compared to the aligned 3D conformations of 
the Y-shaped particles (Fig. 5E), the Fc domains in the X-shaped particles presented with a wider distribution of 
spatial orientations, suggesting that the X-shaped particles have increased flexibility, particularly in the Fc domain.
To quantify the conformational flexibility of the Fc domains, we analyzed the distribution of distances between 
the centers of the CH3 domains and the distribution of angles between the CH2 domains of the 48 X-shaped par-
ticles. The histogram of the distances (fitted by a 2-term Gaussian model) showed that ~72.1% of the X-shaped 
particles have CH3 distances ranging from 70–110 Å (Fig. 5G). The angles measured between two CH2 domains 
were distributed in a range of 0° to 180° (Fig. 5H). The histogram of the angles showed no obvious peak popula-
tion, suggesting that two halves of the Fc domains can move and rotate freely, with little constraint or force against 
each other.
Likewise, to quantify the conformational flexibility between two Fab domains of X-shaped particles, and to 
compare it to that of regular Y-shaped particles reported before49, the distances and angles between Fab domains 
were measured. The histogram of the distances from ~50 to ~115 Å (Fig. 5I, fitted by a 1-term Gaussian model) 
showed a peak population at a distance of ~85 Å. The histogram of the angles from ~10° to 180° (Fig. 5J, mostly 
asymmetrical, therefore fitted by a sixth-degree polynomial curve) showed a peak at ~130°. The distributions of 
distances and angles were similar to those of the published IgG149 by IPET (Fig. 5I,J, dashed lines). In addition, 
the peak distance and angle of the X-shaped particles (~85 Å and ~130°) were similar to the distance and angle 
measured between two Fab domains in the IgG1 crystal structure (~89 Å and ~140°, PDB entry 1HZH). These 
results suggested that the flexibility of the two CH3 domains within the Fc domain does not influence the flexibil-
ity of the two Fab domains. This may result from the highly flexible hinge region that decouples conformational 
changes in the Fc domain from the F domains.
Discussion
EM images give insight into the structural variety of the IgG homodimer, especially the interactions between the 
heavy chain segments forming the Fc domain (CH2 and CH3 domains). In addition to the Y-shaped conforma-
tions seen in the reported IgG1 molecules49, X-shaped conformations were also observed, in which the two heavy 
chain segments of the Fc domain are apart. These results are also consistent with previous biophysical studies27.
Structural interpretation of the interaction between two CH3 chains. The IPET reconstructions 
show that the interaction between the two halves of the Fc domain in X-shaped IgG hole-hole homodimers 
is weakened compared to that of Y-shaped particles, which allows the two halves to move freely. To aid in the 
structural interpretation of this observation, we used the crystal structure of an IgG1 (PDB: 1HZH) as a template, 
as well as an Fc fragment with hole-hole mutations (PDB entry 4NQT)94 as a template to construct a homol-
ogy model of the IgG hole-hole homodimer (see Methods). The crystal structure of IgG1 shows that multiple 
residues contribute to the interaction between two CH3 domains in forming the Fc domain. The interactions 
include (i) hydrogen bonding between T366 and Y40795, which are within hydrogen-bonding distance, as 
reported95; (ii) π-stacking between Y407 residues, where the benzene rings of two Y407 residues in the two halves 
of the Fc domain are located side-by-side with a distance of 4.31 Å, as an energetically stable conformation from 
π-stacking96; and (iii) inter-domain hydrogen bonding mediated by a network of water molecules97.
In the hole-hole homodimer, mutations were introduced into the Fc domain (T366S, L368A and Y407V27), 
located at the CH3-CH3 interface (Supplementary Fig. 46A). These mutations seem to reduce the interactions 
between two CH3 domains (Supplementary Fig. 46B). It is plausible that upon mutation, V407 and S366 become 
too far from each other to maintain the original hydrogen bond. Additionally, the mutation from tyrosine to 
valine removes the original π-stacking interaction between the two Y407 residues. Together, these mutations lead 
to reduced interactions between CH3 domains, thus the two CH3 domains can move freely from each other and 
lead to the observation of X-shaped particles in the homodimer. Hydrogen-deuterium exchange mass spectrom-
etry also shows decreased protection of the same regions in the CH3 domains, consistent with fewer interactions27.
Interestingly, Y-shaped homodimer particles with intact Fc domains were still observed in the homodimer 
sample, suggesting that the two halves of the Fc domain still maintain some interactions after mutation, but with 
the distance between centers of Fab domains (left) and the histogram of the measured distance (right). The 
histogram was fitted by using Gaussian model, and compared with the distance curve reported for Y-shaped 
IgG49. (J) Schematic model illustrating the angle between Fab domains (left) and the histogram of the measured 
angle (right). The histogram was fitted by using sixth degree polynomial curve and compared with the angle 
curve reported for regular IgG49.
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reduced strength. For example, the mutation of hydrophilic Y407 to hydrophobic V407 increases the hydropho-
bicity of the local surface (Supplementary Fig. 46C,D), and therefore may increase the nonspecific hydrophobic 
interactions between the two halves of the Fc domain. The observation of both X- and Y-shaped particles may 
relate to the equilibrium between the conformations.
Minor components in the hole-hole homodimer sample. In addition to Y- and X-shaped particles, 
low percentages of bow-tie-shaped particles (~10.0%) and i-shaped particles (~2.5%) were also observed in the 
sample of IgG hole-hole homodimer (Figs 1D and 4A,E,F). The bow-tie-shaped particles contain two domains 
that are similar to each other in size and shape, and similar to the Fab domains in the Y- and X-shaped particles. 
However, the third domain, likely the Fc domain, is not seen. Given that physically truncated homodimers were 
not detected by chromatography, native MS or HDX-MS27, the apparently absent Fc domain is likely still present 
but denatured or disordered, resulting in a lack of visibility in EM images.
The i-shaped particles have an overall diameter of ~110 Å, with a similar size and shape to half of an X-shaped 
IgG. These particles are likely formed by Fab domain and half of an Fc domain (Fig. 4A,B), i.e. a single heavy and 
light chain. This hypothesis is consistent with our previous study in which a species with half of an intact IgG mass 
was identified in the hole-hole homodimer sample by native MS27. However, in that study the species observed 
by native MS could not be reliably detected by SEC, possibly due to its low abundance. Our 16 IPET maps of 
i-shaped particles showed that the particle is composed of a large and a small globular domain, which are similar 
to half of the X-shaped antibody in size and shape (Fig. 4C and Supplementary Figs 36–45). By flexibly fitting a 
half-antibody model into each map (Fig. 4D and Supplementary Figs 36–45), the agreement in overall size and 
shape strongly supports the hypothesis that the i-shaped particles are halves of antibodies. The observation of 
half-antibodies, especially the half Fc domain (approximately 25 kDa), is far below the limitations of EM imaging 
using other methods, suggesting that the combination of the OpNS and IPET methods can be used as a supple-
mentary tool to study the structure of small and flexible proteins, including therapeutic IgGs.
Conclusion
In this study, we characterized the newly discovered X-shaped particles in a hole-hole homodimer using NS-EM 
with IPET technology. Through the 3D reconstruction of 64 individual particles, we confirmed that the apparent 
X-shape was due to the weakened interaction between the two halves of the Fc domain of this homodimer. The 
X-shaped particle was not observed in regular IgG1 samples. The weakened interaction between the two halves of 
the Fc domain in the homodimer appears to be due to the mutations in the CH3 domain. We also observed several 
minor species using the IPET method. Our study demonstrates the capability of the IPET with NS-EM method in 
the topological study of small and flexible proteins in heterogeneous samples, as a supplementary tool for future 
engineering optimization of therapeutic antibodies.
Methods
Production of the hole−hole homodimer and NISTmAb. The hole-hole homodimer was produced as 
described in literature27. In brief, the harvested cell culture fluid containing the hole half antibody was first puri-
fied on protein-A affinity chromatography. The pH of the protein-A pool was adjusted from 3.3 to 5.0, and Poros 
cation exchange chromatography was used to separate the hole-hole homodimer from the half antibody and other 
species. The resulting solution was then eluted at pH 5.5. The solution was finally submitted to ultrafiltration/
diafiltration and conditioned at pH 5.8 in 20 mM histidine acetate buffer. Intact mass analysis confirmed that the 
hole-hole homodimer was a covalent homodimer. The NISTmAb is a recombinant, humanized IgG1 expressed in 
a murine suspension culture74, and is available as a reference material (RM 8671). As supplied, the reference mate-
rial (lot 14HB-D-002) typically contains approximately 3% oligomers (dimer/trimer) by mass. For EM studies, 
monomeric NISTmAb was isolated by size exclusion chromatography in phosphate buffered saline (PBS) using a 
Superdex 200 16/60 Prep Grade column (GE Healthcare) and flash-frozen until needed.
Preparation of OpNS-EM specimens. The OpNS specimens of IgG hole-hole homodimers and 
the NISTmAb were prepared by using the protocol as described35–38. In brief, IgG samples were diluted to 
~0.04 μg mL−1 with Dulbecco’s phosphate-buffered saline (DPBS). An aliquot (approximately 4 μL) of diluted 
sample was placed on an ultra-thin carbon-coated 200-mesh copper grid (CF200-Cu-UL, Electron Microscopy 
Sciences, Hatfield, PA, USA, and Cu-200CN, Pacific Grid-Tech, San Francisco, CA, USA) that had been 
glow-discharged for 15 s. After 1-min incubation, the excess solution on the grid was blotted with filter paper. The 
grid was then washed with water and stained with 1% (w/v) uranyl formate (UF) before air-drying with nitrogen.
TEM un-tilted data acquisition and image processing. OpNS samples were examined by using a Zeiss 
Libra 120 Plus TEM (Carl Zeiss NTS) operated at 120 kV high tension with a 10–20 eV energy filter. The OpNS 
micrographs were acquired under defocus at ~0.6 μm to ~0.9 μm and a dose of ~40–90 e−Å−2 using a Gatan 
UltraScan 4 K X 4 K CCD under a magnification of 80 kx (each pixel of the micrographs corresponds to 1.48 Å in 
specimens). The contrast transfer function (CTF) of each micrograph was examined by using ctffind3 software98 
and corrected by using the “TF CTS” command in SPIDER99 software or GCTF100 after the X-ray speckles were 
removed. Particles were then selected from the micrographs with a box size of 192 × 192 by using boxer (EMAN78 
software). All particles were masked by using a round mask generated from SPIDER software after a Gaussian 
high-pass filtering. The reference-free class averages of particles were obtained by using refine2d (EMAN soft-
ware) based on 13,546 particles of hole-hole homodimer and 4,961 particles of NISTmAb.
Overall structure of X-shaped particles in IgG homodimer and half-IgG by 2D mapping. Although 
individual images or class averages provide only 2D information of the particles and are insufficient to determine 
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their 3D structures, raw images and class averages with high contrast could still provide important clues about the 
3D orientation or even the overall structure of the particles. Here, we tried to determine the overall structure of 
the X-shaped particles in IgG homodimer by flexibly superposing an IgG model (the crystal structure of a human 
IgGl, PDB entry 1HZH41) onto images or class averages via the following protocol. First, the missing residues in 
the crystal structure were recovered using UCSF Chimera software. Next, the two Fab domains and the two heavy 
chain Fc regions in the crystal structure were separately rigid-body translated/rotated to obtain the best-fit for 
the corresponding domains obtained from images or class averages. To distinguish Fab domains from Fc regions 
obtained from the images and averages, the following criteria were used: i) two Fab domains are similar in size 
and shape; ii) the two halves of the Fc are both distinguishably smaller than an Fab domain. The above protocol 
was also used for determining the overall structure of half-IgG.
Conformations of IgG homodimer and half-IgG. The resolution (approximately 12–15 Å) of the IPET 
3D reconstructions was insufficient to determine the high-resolution atomic structure of each individual IgG. 
However, the reconstructions were sufficient to determine the overall domain orientations and positions and 
reveal the structural heterogeneity and dynamics of the homodimer with mutations in the Fc region. We chose 
the crystal structure of human IgG (PDB entry 1HZH41) as a model to reflect the IgG structural dynamics and 
flexibly docked it into the reconstruction of homodimer and half-IgG by using the following protocol. After the 
missing residues in the crystal structure were recovered by using Chimera, the Fab domains and heavy chain Fc 
regions were truncated from the crystal structure and separately rigid-body docked into the density map envelope 
using Chimera. Finally, the positions and orientations of the docked domains were used as guides for performing 
targeted molecular dynamics (TMD) simulations.
To distinguish Fab domains from the heavy chain Fc region and determine their overall location and orien-
tation in the 3D density maps, the following criteria were used in addition to these in the previous section: the 
distance between the Fab domain and corresponding heavy chain Fc region should be allowed by the length of 
central loop.
By using the best-fit positions as the target positions, we drove the model to correlate with the density map 
by using a TMD simulation technique. The dragging and moving forces were pre-calculated and applied to all 
backbone atoms in each domain of the crystal structure to gradually steer the domains toward their correspond-
ing best-fit positions and orientations. During this process, the domain structure and the chemical structure, 
including disulfide bonds, were constrained as the original crystal structure, whereas the loop regions were left 
flexible, allowing conformational changes to occur. As a result, the newly modeled structure of the IgG had the 
same domain structure as in the crystal structure, but had different relative domain positions and orientations.
The TMD simulation was performed using the NAMD2101 software and CHARMM27102 force fields. A cut-off 
distance for van der Waals interactions was set to 12 Å. The whole system was heated from 0 K to 310 K over a 
62-ps simulation using weakly coupled Langevin dynamics, and the temperature was then maintained at 310 K. 
The pressure was maintained at 1 atm using a Langevin piston Nose-Hoover barostat (with a piston period of 
100 fs and a decay time of 50 fs). It took 300 k steps to complete the conformational changes, and the simulation 
length was 0.6 ns.
ET data acquisition and image pre-processing. The TEM holder was tilted at angles ranging from 
−45° to +45° in 1.5° increments, and imaging was controlled using Gatan tomography software (Zeiss Libra 
120 Plus TEM). The TEM was operated at 120 kV high tension with a 20-eV energy filter. The tilt series was 
acquired under low defocus conditions (<1 μm) using a Gatan UltraScan 4 K X 4 K CCD under a magnifica-
tion of 80 kx (each pixel of the micrographs corresponds to 1.48 Å in specimens). The total electron doses were 
2,800–6,600 e−Å−2. The micrographs were initially aligned using the IMOD103 software package. The CTF was 
then corrected using TomoCTF104. The tilt series of the particles in square windows of 256 × 256 pixels (~38 nm) 
were semi-automatically tracked, windowed using IPET software39, and finally binned by 2 to reduce computation 
time in the subsequent reconstruction.
IPET 3D reconstruction. In the IPET reconstruction process39, a tilt series of CTF-corrected images 
(~38 nm) containing a single IgG homodimer or half-IgG particle was directly back-projected into an ab initio 
3D density map as an initial model based on the corresponding goniometer tilt angles of images. The refinement 
was started using this initial model to align each tilt image via translational alignment to the projections of the ini-
tial model. During refinement, automatically generated low-pass filters, a circular-shaped mask with a Gaussian 
boundary, and particle-shaped masks with a Gaussian boundary were sequentially applied to the tilt images and 
references to increase the alignment accuracy39. The resolution was defined based on Fourier shell correction 
(FSC) calculation, in which the aligned images were split into two halves based on an odd- or even-numbered 
index to generate two 3D reconstructions for computing their FSC curve against the spatial frequency shells in 
Fourier space. The frequency at which the FSC curve first fell to a value of 0.5 was used to represent the resolution 
of the IPET 3D density map. All IPET density maps presented in the figures were low-pass filtered to 20 Å.
Notably, a tilt angle range of ±45° was used for IPET 3D reconstruction, which could lead to missing wedge 
artifacts, such as elongation, blurring, and distracting caustics105. However, the effects of the missing wedge can 
be reduced via computational algorithms as reported by numerous groups105–108. Agard and Stroud reported a 
computational approach to fill the missing data in 2D electron crystallography109. Recently, Kovacik, et al. used 
a simple Fourier angular filter106, Ruotsalainen et al. developed a statistical reconstruction method110, Sun et al. 
reported an iterative compressed-sensing107, and Miao et al. proposed a generalized Fourier iterative reconstruc-
tion algorithm (GENFIRE) to reduce the missing wedge artifact to achieve a 3D structure with more isotropic 
resolution108. In our IPET 3D reconstruction, we used our real-Fourier space iteration algorithm to fill the miss-
ing wedge51,52,57,58. The related methodology paper is in preparation.
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Statistical analysis of IgG homodimer dynamics. To quantify the conformational dynamics of the IgG 
homodimers, all 64 IgG homodimer conformations were aligned based on their CH2 domains using VMD soft-
ware111. The distribution of distance and angle between Fab domains, distance between CH3 domains and angle 
between CH2 domains were then measured to study the fluctuations and dynamic features of the IgG homodimer. 
To measure distance, we first calculated the mass center of each Fab and CH3 domain and then measured the 
distance between the mass centers of the Fab domains (Fig. 5I), and between the mass centers of the CH3 domains 
(Fig. 5G). To measure angles, we first introduced vectors to determine the orientation of each Fab domain and 
each CH2 domain (Fig. 5H,J), and then measured angles between the vectors. These vectors were defined by using 
backbone atoms at the two far ends of Fab domains and CH2 domains.
The measured distances and angles from 48 X-shaped IgG homodimers were plotted onto histograms and fit-
ted with polynomial or Gaussian curves using MATLAB. These histograms represented the conformational space 
of the IgG homodimer and indicated the extent of the structural dynamics of the homodimer.
Construction of a homology model for IgG homodimer Fc domain. To study contacts between CH3 
domains after hole mutations, a homology model for the Fc domain of the hole-hole homodimer was constructed. 
First, the two halves of the Fc region with hole mutations were derived from the crystal structure of homodimeric 
hole Fc fragment (PDB entry 4NQT94). The two halves were then separately superposed onto the corresponding 
halves of Fc region in the typical IgG using Chimera.
Data deposition. The TEM 3D density maps of 64 IgG homodimers and 16 half-IgGs are available from the 
EM data bank as EMDB IDs 7353–7368, 7369–7417 and 7418–7433.
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